{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:46:31Z","timestamp":1761929191511},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychosomatic Research"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1016\/s0022-3999(02)00583-4","type":"journal-article","created":{"date-parts":[[2003,6,30]],"date-time":"2003-06-30T17:29:20Z","timestamp":1056994160000},"page":"49-57","source":"Crossref","is-referenced-by-count":34,"title":["How to treat OCD in patients with Tourette syndrome"],"prefix":"10.1016","volume":"55","author":[{"given":"Eur\u0131\u0301pedes C","family":"Miguel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roseli Gedanke","family":"Shavitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ygor A","family":"Ferr\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9rgio A","family":"Brotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana B","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0022-3999(02)00583-4_BIB1","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","year":"1994"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/ajp.151.5.675","article-title":"\u201cJust-right\u201d perceptions associated with compulsive behavior in Tourette's syndrome","volume":"151","author":"Leckman","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1176\/ajp.149.9.1244","article-title":"Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children","volume":"149","author":"Leonard","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB4","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/archpsyc.1986.01800120066013","article-title":"Gilles de la Tourette's syndrome and obsessive-compulsive disorder: evidence supporting a genetic relationship","volume":"43","author":"Pauls","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM198610163151604","article-title":"The inheritance of Gilles de la Tourette's syndrome and associated behavior-evidence for autosomal dominant transmission","volume":"315","author":"Pauls","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1192\/bjp.162.5.593","article-title":"Evidence for autosomal dominant transmission in Tourette's syndrome\u2014United Kingdom Cohort Study","volume":"162","author":"Eapen","year":"1993","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/ajp.152.1.76","article-title":"A family study of obsessive-compulsive disorder","volume":"152","author":"Pauls","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00004714-199310000-00008","article-title":"The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder","volume":"13","author":"McDougle","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archpsyc.1994.03950040046006","article-title":"Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo-controlled study in patients with and without tics","volume":"51","author":"McDougle","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/ajp.152.3.441","article-title":"Family accommodation in obsessive-compulsive disorder","volume":"152","author":"Calvocoressi","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB11","series-title":"Current treatments of obsessive-compulsive disorder","first-page":"133","article-title":"Individual, group and multifamily cognitive-behavioral treatments","author":"Van Noppen","year":"2001"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archpsyc.1995.03950130053006","article-title":"Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: a meta-analysis","volume":"52","author":"Greist","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB13","series-title":"Obsessive-compulsive disorders\u2014practical management","first-page":"592","article-title":"Neurosurgical treatment of obsessive-compulsive disorder","author":"Jenike","year":"1998"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB14","unstructured":"Gabri\u00ebls L, Cosyns P, Nuttin, B. Therapeutic effects of deep brain stimulation in patients with obsessive-compulsive disorder. Textbook of 5th International Obsessive-Compulsive Conference, 2001, Sardinia, Italy."},{"key":"10.1016\/S0022-3999(02)00583-4_BIB15","unstructured":"Greenberg BD. Brain stimulation in OCD research and treatment. In: Vallejo J, Sanchez-Planell, editors. Barcelona (Spain): Patologia Obsesiva (in press)."},{"key":"10.1016\/S0022-3999(02)00583-4_BIB16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0165-1781(99)00104-3","article-title":"Predictors of course in obsessive-compulsive disorder","volume":"89","author":"Steketee","year":"1999","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.1016\/S0022-3999(02)00583-4_BIB17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1037\/0022-006X.62.4.801","article-title":"Relapse prevention program for treatment of obsessive-compulsive disorder","volume":"62","author":"Hiss","year":"1994","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB18","series-title":"Obsessive-compulsive disorders: pathogenesis, diagnosis and treatment","first-page":"173","article-title":"Biological therapy","author":"Yaryura-Tobias","year":"1983"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB19","series-title":"Obsessive-compulsive disorders\u2014practical management","first-page":"368","article-title":"Cognitive theory and treatment of obsessive-compulsive disorder","author":"Steketee","year":"1998"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB20","first-page":"272","article-title":"A time-limited behavioral group for the treatment of obsessive-compulsive disorder","volume":"7","author":"Van Noppen","year":"1998","journal-title":"J Psychother Pract Res"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB21","series-title":"Biobehavioral treatment of obsessive-compulsive spectrum disorders","first-page":"76","article-title":"Conducting behavior and cognitive therapy","author":"Yaryura-Tobias","year":"1997"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB22","series-title":"Advances in neurology\u2014vol. 85\u2014Tourette syndrome","first-page":"43","article-title":"The tic-related obsessive-compulsive disorder phenotype and treatment implications","author":"Miguel","year":"2001"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB23","series-title":"Advances in neurology\u2014vol. 85\u2014Tourette syndrome","first-page":"319","article-title":"Behavioral treatments for Tourette syndrome and tic disorders: state of the art","author":"Piacentini","year":"2001"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB24","series-title":"Obsessive-compulsive disorders\u2014practical management","first-page":"611","article-title":"Psychotherapy of obsessive-compulsive personality disorder","author":"Jenike","year":"1998"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB25","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/archpsyc.1991.01810320054008","article-title":"Efficacy of clomipramine in OCD: results of a multicenter double-blind trial","volume":"48","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB26","first-page":"195","article-title":"Efficacy of fluvoxamine in obsessive-compulsive disorder: results of a multicentre, double-blind, placebo-controlled trial","volume":"7","author":"Greist","year":"1995","journal-title":"Eur J Clin Res"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004850-199603000-00003","article-title":"Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo controlled study","volume":"11","author":"Goodman","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004850-199506000-00001","article-title":"A 1-year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder","volume":"10","author":"Greist","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB29","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.280.20.1752","article-title":"Sertraline in children and adults with obsessive-compulsive disorder: a multicenter randomized controlled trial","volume":"280","author":"March","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archpsyc.1994.03950070051010","article-title":"A multi-center investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder","volume":"51","author":"Tollefson","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004583-199001000-00008","article-title":"Fluoxetine treatment of children and adolescents with Tourette's and OCD: preliminary clinical experience","volume":"29","author":"Riddle","year":"1990","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB32","article-title":"A fixed dose comparison of 20, 40 or 60 mg paroxetine to placebo in the treatment of obsessive-compulsive disorder","author":"Wheadon","year":"1993"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB33","first-page":"19","article-title":"Beyond depression: citalopram for obsessive-compulsive disorder","volume":"14","author":"Pato","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-0327(87)90023-1","article-title":"Drug treatment of obsessive-compulsive disorder","volume":"13","author":"Zohar","year":"1987","journal-title":"J Affect Disord"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1192\/bjp.166.4.424","article-title":"Efficacy of drug treatment in OCD: a metaanalysis review","volume":"166","author":"Piccinelli","year":"1995","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00004714-199004000-00008","article-title":"Clomipramine versus fluoxetine in OCD: a retrospective comparison of side effects and efficacy","volume":"10","author":"Jenike","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB37","first-page":"301","article-title":"Fluovoxamine versus clomipramine in the treatment of obsessive-compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison","volume":"55","author":"Freeman","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0924-9338(97)89646-0","article-title":"A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder","volume":"12","author":"Bisserbe","year":"1997","journal-title":"Eur Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1192\/bjp.169.4.468","article-title":"Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder","volume":"169","author":"Zohar","year":"1996","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/S0022-3999(02)00583-4_BIB40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004850-200015020-00002","article-title":"Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder","volume":"15","author":"Mundo","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1192\/bjp.161.5.665","article-title":"Clomipramine versus phenelzine in obsessive-compulsive disorder\u2014a controlled clinical trial","volume":"161","author":"Vallejo","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB42","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1176\/ajp.154.9.1261","article-title":"A placebo controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder","volume":"154","author":"Jenike","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB43","series-title":"Obsessive-compulsive disorders\u2014practical management","first-page":"3","article-title":"An overview of obsessive-compulsive disorder","author":"Jenike","year":"1998"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB44","first-page":"13","article-title":"Pharmacological options for refractory OCD","author":"Zohar","year":"2001"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB45","unstructured":"Ros\u00e1rio-Campos MC, Leckman JF, Mercadante MT, et al. Early-onset obsessive-compulsive disorder as a possible subgroup. Am J Psychiatry (in press)."},{"issue":"4","key":"10.1016\/S0022-3999(02)00583-4_BIB46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00004714-199408000-00004","article-title":"Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine","volume":"14","author":"Ackerman","year":"1994","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/S0022-3999(02)00583-4_BIB47","first-page":"368","article-title":"Predictors of drug treatment response in obsessive-compulsive disorder","volume":"56","author":"Ravizza","year":"1995","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/S0022-3999(02)00583-4_BIB48","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4088\/JCP.v59n0804","article-title":"Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder","volume":"59","author":"Black","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB49","first-page":"9","article-title":"Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder","volume":"156","author":"Mattaix-Cols","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00004714-199306000-00010","article-title":"A predictive study of obsessive-compulsive disorder response to clomipramine","volume":"13","author":"Alarcon","year":"1993","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/S0022-3999(02)00583-4_BIB51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1590\/S1516-44461999000400009","article-title":"Overvalued ideas and their impact on treatment outcome","volume":"21","author":"Neziroglu","year":"1999","journal-title":"Rev Bras Psiquiatr"},{"issue":"5","key":"10.1016\/S0022-3999(02)00583-4_BIB52","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1176\/ajp.147.5.652","article-title":"Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder","volume":"147","author":"McDougle","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0887-6185(87)90032-6","article-title":"Schizotypal personality disorder: a poor prognostic indicator for behavior therapy in the treatment of obsessive-compulsive disorder","volume":"1","author":"Minichiello","year":"1987","journal-title":"J Anxiety Disord"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB54","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archpsyc.1992.01820110026003","article-title":"Effect of axis II diagnoses on treatment outcome with clomipramine in 54 patients with obsessive-compulsive disorder","volume":"49","author":"Baer","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/S0022-3999(02)00583-4_BIB55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0924-977X(96)00382-3","article-title":"Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment","volume":"7","author":"Cavedini","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB56","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00004583-199303000-00017","article-title":"Desipramine treatment of children with attention deficit hyperactivity disorder and tic disorder or Tourette's syndrome","volume":"32","author":"Spencer","year":"1993","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB57","doi-asserted-by":"crossref","unstructured":"Guy W. Early Clinical Drug Evaluation Unit (ECDEU) assessment manual for psychopharmacology. Revised. NIMH Publication DHEW Publ. No. (Adm) 76-3[38]. Bethesda (MD): National Institute of Mental Health, 1976. pp. 217\u201322.","DOI":"10.1037\/e591322011-001"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/09540269775574","article-title":"The role of neurotransmitters and neurohormones in obsessive-compulsive disorder","volume":"9","author":"Greenberg","year":"1997","journal-title":"Int Rev Psychiatry"},{"issue":"2","key":"10.1016\/S0022-3999(02)00583-4_BIB59","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2165\/00003495-199243020-00007","article-title":"Current concepts in the pharmacological treatment of obsessive-compulsive disorder","volume":"43","author":"Zohar","year":"1992","journal-title":"Drugs"},{"issue":"Suppl. 3","key":"10.1016\/S0022-3999(02)00583-4_BIB60","first-page":"24","article-title":"Dopamine antagonists in tic-related and psychotic spectrum obsessive-compulsive disorder","volume":"55","author":"Mc Dougle","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1016\/S0022-3999(02)00583-4_BIB61","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1176\/ajp.152.12.1812","article-title":"Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder","volume":"152","author":"McDougle","year":"1995","journal-title":"Am J Psychiatry"},{"issue":"9","key":"10.1016\/S0022-3999(02)00583-4_BIB62","first-page":"423","article-title":"Risperidone in the treatment of affective illness and obsessive-compulsive disorder","volume":"56","author":"Jacobsen","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB63","unstructured":"Saxena S, Wang D, Bystritsky A, Baxter LRJ. Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. J Clin Psychiatry 57(7) (in press)."},{"issue":"8","key":"10.1016\/S0022-3999(02)00583-4_BIB64","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","article-title":"A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder","volume":"57","author":"McDougle","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1016\/S0022-3999(02)00583-4_BIB65","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4088\/JCP.v60n0804","article-title":"Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series","volume":"60","author":"Weiss","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/S0022-3999(02)00583-4_BIB66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-1781(00)00203-1","article-title":"Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial","volume":"96","author":"Bogetto","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB67","first-page":"22","article-title":"Augmentation of SSRI response in refractory OCD using adjunctive olanzapine: a placebo-controlled trial","author":"Bystritsky","year":"2001"},{"issue":"4","key":"10.1016\/S0022-3999(02)00583-4_BIB68","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0193-953X(18)30211-9","article-title":"Neurobiology of obsessive compulsive disorder","volume":"15","author":"Insel","year":"1992","journal-title":"Psychiatr Clin North Am"},{"issue":"12","key":"10.1016\/S0022-3999(02)00583-4_BIB69","first-page":"439","article-title":"Emergence of obsessive compulsive symptoms during treatment with clozapine","volume":"53","author":"Baker","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB70","first-page":"836","article-title":"Development of obsessive-compulsive symptoms during clozapine treatment","volume":"159","author":"Patil","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/S0022-3999(02)00583-4_BIB71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00004714-199302000-00004","article-title":"A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients","volume":"13","author":"Chouinard","year":"1993","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/S0022-3999(02)00583-4_BIB72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-2000-8360","article-title":"Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs","volume":"33","author":"Ramassubo","year":"2000","journal-title":"Pharmacopsychiatry"},{"issue":"10","key":"10.1016\/S0022-3999(02)00583-4_BIB73","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archpsyc.55.10.918","article-title":"Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study","volume":"55","author":"Fallon","year":"1998","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/S0022-3999(02)00583-4_BIB74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0924-977X(97)00048-5","article-title":"Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder","volume":"8","author":"Koran","year":"1998","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/S0022-3999(02)00583-4_BIB75","first-page":"285","article-title":"Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination","volume":"26","author":"Simeon","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB76","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/070674379303800402","article-title":"The benefits of clomipramine\u2013fluoxetine combination in obsessive-compulsive disorder","volume":"38","author":"Browne","year":"1993","journal-title":"Can J Psychiatry"},{"issue":"1","key":"10.1016\/S0022-3999(02)00583-4_BIB77","first-page":"167","article-title":"Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs)","volume":"32","author":"Ravizza","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB78","series-title":"Obsessive-compulsive and related disorders in adults\u2014a comprehensive clinical guide","first-page":"55","article-title":"Obsessive-compulsive disorder and its treatment","author":"Koran","year":"1999"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB79","first-page":"121","article-title":"Citalopram plus clomipamine for treatment resistant obsessive-compulsive disorder","volume":"8","author":"Pallanti","year":"1998","journal-title":"Eur Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB80","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1176\/ajp.141.10.1283","article-title":"Lithium and tryptophan augmentation in clomipramine resistant obsessive-compulsive disorder","volume":"141","author":"Rasmussen","year":"1984","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/S0022-3999(02)00583-4_BIB81","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00004714-199108000-00004","article-title":"A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder","volume":"11","author":"Pigott","year":"1991","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/S0022-3999(02)00583-4_BIB82","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004714-199106000-00005","article-title":"A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy","volume":"11","author":"McDougle","year":"1991","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/S0022-3999(02)00583-4_BIB83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004714-199202000-00003","article-title":"A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder","volume":"12","author":"Pigott","year":"1992","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/S0022-3999(02)00583-4_BIB84","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1176\/ajp.150.4.647","article-title":"Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder","volume":"150","author":"McDougle","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/S0022-3999(02)00583-4_BIB85","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00004714-199212000-00008","article-title":"Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder","volume":"12","author":"Hewlett","year":"1992","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/S0022-3999(02)00583-4_BIB86","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00004850-199809000-00005","article-title":"Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study","volume":"13","author":"Mundo","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB87","unstructured":"Dannon PN, Zohar J, Hirschmann S, et al. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial (in press)."},{"issue":"1","key":"10.1016\/S0022-3999(02)00583-4_BIB88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004850-199603000-00005","article-title":"Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder: preliminary findings","volume":"11","author":"Blier","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB89","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00004850-198604000-00008","article-title":"A pilot study of combined trazodone and tryptophan in OCD","volume":"1","author":"Mattes","year":"1986","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB90","first-page":"15","article-title":"Approaches to the patient with treatment-refractory obsessive compulsive disorder","volume":"51","author":"Jenike","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB91","series-title":"Obsessive-Compulsive Foundation pamphlet","article-title":"Drug treatment of OCD in adults","author":"Jenike","year":"1996"},{"issue":"12","key":"10.1016\/S0022-3999(02)00583-4_BIB92","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/archpsyc.1980.01780250036004","article-title":"Clonidine ameliorates Gilles de la Tourette syndrome","volume":"37","author":"Cohen","year":"1980","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/S0022-3999(02)00583-4_BIB93","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/ajp.145.3.388-a","article-title":"Clonidine and clomipramine in obsessive-compulsive disorder","volume":"145","author":"Hollander","year":"1988","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB94","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1176\/ajp.139.3.364","article-title":"Successful treatment of obsessive-compulsive disorder with clonidine hydrochoride","volume":"139","author":"Knesesvich","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB95","series-title":"Obsessive-compulsive disorders\u2014practical management","first-page":"469","article-title":"Drug treatment of obsessive-compulsive disorders","author":"Jenike","year":"1998"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB96","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB97","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1176\/ajp.154.9.1293","article-title":"Addition of desipramine to serotonin reuptake inhibitors in treatment resistant obsessive-compulsive disorder","volume":"154","author":"Barr","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB98","first-page":"28","article-title":"Venlafaxine in obsessive-compulsive disorder","author":"Ravizza","year":"2001"},{"issue":"9","key":"10.1016\/S0022-3999(02)00583-4_BIB99","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1176\/ajp.140.9.1219","article-title":"Naloxone administration in obsessive-compulsive disorder: report of two cases","volume":"140","author":"Insel","year":"1983","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0006-3223(95)00632-X","article-title":"Behavioral effects of naloxone infusion in obsessive-compulsive disorder","volume":"40","author":"Keuler","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB101","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/00207458708987115","article-title":"Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome","volume":"35","author":"Sandik","year":"1987","journal-title":"Int J Neurosci"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB102","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/(SICI)1520-6394(1997)6:4<170::AID-DA7>3.0.CO;2-G","article-title":"Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder","volume":"6","author":"Shapira","year":"1997","journal-title":"Depress Anxiety"},{"issue":"4","key":"10.1016\/S0022-3999(02)00583-4_BIB103","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1176\/ajp.156.4.660a","article-title":"Rapid remission of OCD with tramadol hydrochloride","volume":"156","author":"Goldsmith","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB104","first-page":"18","article-title":"Oral morphine in treatment resistant obsessive-compulsive disorder","author":"Franz","year":"2001"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1212\/WNL.56.5.599","article-title":"Baclofen treatment in Tourette syndrome","volume":"56","author":"Singer","year":"2001","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/S0022-3999(02)00583-4_BIB106","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4088\/JCP.v59n0907d","article-title":"Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder","volume":"59","author":"Cora-Locatelli","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB107","first-page":"23","article-title":"Controlled study of gabapentin augmentation of fluoxetine in OCD: effects on symptoms and on cortical excitability","author":"Greenberg","year":"2001"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB108","series-title":"Obsessive-compulsive disorders: theory and management","article-title":"Obsessive-compulsive disorders in pregnancy and childbirth","author":"Buttolph","year":"1990"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB109","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/ajp.149.7.947","article-title":"Onset of obsessive-compulsive disorder in pregnancy","volume":"149","author":"Neziroglu","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/070674379504000408","article-title":"The influence of gonadal hormones on periodicity of obsessive-compulsive disorder","volume":"40","author":"Weiss","year":"1995","journal-title":"Can J Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB111","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0447.1986.tb10591.x","article-title":"Antiandrogenic treatment of obsessive-compulsive neurosis","volume":"73","author":"Casas","year":"1986","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/S0022-3999(02)00583-4_BIB112","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0193-953X(18)30407-6","article-title":"Pharmacotherapy of childhood obsessive-compulsive disorder","volume":"12","author":"Leonard","year":"1989","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB113","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4530(92)90015-Y","article-title":"Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome","volume":"17","author":"Peterson","year":"1993","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"10.1016\/S0022-3999(02)00583-4_BIB114","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4088\/JCP.v60n0704","article-title":"Open trial of flutamide for treatment of obsessive-compulsive disorder","volume":"60","author":"Altemus","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB115","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood","volume":"354","author":"Perlmutter","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/S0022-3999(02)00583-4_BIB116","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0193-953X(05)70349-X","article-title":"Obsessive-compulsive disorder","volume":"20","author":"Miguel","year":"1997","journal-title":"Psychiatr Clin North Am"},{"issue":"suppl 4","key":"10.1016\/S0022-3999(02)00583-4_BIB117","article-title":"The expert consensus guideline series\u2014treatment of obsessive-compulsive disorder","volume":"58","author":"March","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB118","first-page":"21","article-title":"Anterior gamma capsulotomy for intractable OCD","author":"Rasmussen","year":"2001"},{"issue":"2","key":"10.1016\/S0022-3999(02)00583-4_BIB119","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1516-44462001000200009","article-title":"A review of the minimally invasive brain stimulation techniques in psychiatry","volume":"23","author":"Chae","year":"2001","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB120","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1176\/appi.ajp.158.7.1143","article-title":"Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind placebo-controlled study","volume":"158","author":"Alonso","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/S0022-3999(02)00583-4_BIB121","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0193-953X(05)70348-8","article-title":"Tic disorders","volume":"20","author":"Leckman","year":"1997","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB122","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/sj.mp.4000391","article-title":"Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive-compulsive disorder","volume":"3","author":"McDougle","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S0022-3999(02)00583-4_BIB123","series-title":"The doctor, his patient and the illness","author":"Balint","year":"1956"}],"container-title":["Journal of Psychosomatic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399902005834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399902005834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T06:06:19Z","timestamp":1704866779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022399902005834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["S0022399902005834"],"URL":"https:\/\/doi.org\/10.1016\/s0022-3999(02)00583-4","relation":{},"ISSN":["0022-3999"],"issn-type":[{"value":"0022-3999","type":"print"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}